Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No fatwolit, you're wrong, it has little to do with my not agreeing with tcr,

You state

And then there's the ongoing opinion he expresses that S&L was exposed to ZERO risk when they invested in PTSC to keep us afloat. Does anyone really believe that? If there were zero risk, why didn't B&A invest? Why did they need an investor, on those terms, to begin with?

I believe that. S & L set it up so they made money if they sold the stock at 5, .50, .05, or .005. They had limited if not zero risk. Correct me if I am wrong but I believe that it has already been established that PTSC was also paying interest on the debentures and to add insult to shareholder injury, it was in S & L's best interest to hold prices down in that the amount of debentures that they were issued was tied to the price of the stock.

Share
New Message
Please login to post a reply